The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

JAK Inhibitor Timing Affects Zoster Vaccine Response in RA

Immediate initiation of JAK inhibitor therapy after recombinant zoster vaccination is linked to lower early immune responses than delayed initiation in patients with rheumatoid arthritis.

Temocillin: Old Antibiotic Finds a New Role

Temocillin is non-inferior to carbapenems for resistant Enterobacterales bacteraemia, offering a safe, carbapenem-sparing treatment option for patients with the infection.

Cyclosporiasis: 3 Things to Know About Diagnosis, Management

Awareness, early recognition, and appropriate testing are key.

SLE Linked to Higher Risk for Mortality After Heart Attack

Systemic lupus erythematosus is associated with higher risks for all-cause and cardiovascular mortality for up to 5 years after acute myocardial infarction, a study finds.

What’s Driving Negligence Claims in the ED?

From safety netting to documentation, understanding the five themes driving claims in emergency departments could help to protect patients and doctors.

Aid Group Says Seven Americans Quarantining At Kenya Ebola Facility After US Travel Ban

Seven American aid workers who had been in Congo to fight the Ebola outbreak are quarantining at a new isolation facility in Kenya after the U.S. government introduced...

Todays Updates

Faricimab May Aid Hard-to-Treat Macular Degeneration Cases

Faricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration.

Delays Harmless for Most Macular Degeneration Patients

Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss.

US FDA Says False-positive Lettuce Test Doesn't Change Taylor Farms Cyclospora Probe

The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be ⁠a false positive for cyclospora, saying the reversal does not...

What Has Made the Cyclospora Behind the US Outbreak So Challenging to Trace?

Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...

Sri Lanka Uses Air Force Drones to Tackle Spreading Dengue Outbreak

Sri Lanka's public health services and hospitals are battling the worst outbreak of mosquito-borne dengue in nearly a decade, and turning to the island nation's armed...

Older Adults Have Worse Lower GI Bleeding Outcomes

Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.

CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

Todays Updates

Faricimab May Aid Hard-to-Treat Macular Degeneration Cases

Faricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration.

Delays Harmless for Most Macular Degeneration Patients

Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss.

US FDA Says False-positive Lettuce Test Doesn't Change Taylor Farms Cyclospora Probe

The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be ⁠a false positive for cyclospora, saying the reversal does not...

What Has Made the Cyclospora Behind the US Outbreak So Challenging to Trace?

Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...

Sri Lanka Uses Air Force Drones to Tackle Spreading Dengue Outbreak

Sri Lanka's public health services and hospitals are battling the worst outbreak of mosquito-borne dengue in nearly a decade, and turning to the island nation's armed...

Older Adults Have Worse Lower GI Bleeding Outcomes

Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.

CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

Latest News

Immediate initiation of JAK inhibitor therapy after recombinant zoster vaccination is linked to lower early immune responses than delayed initiation in patients with rheumatoid arthritis.

Temocillin is non-inferior to carbapenems for resistant Enterobacterales bacteraemia, offering a safe, carbapenem-sparing treatment option for patients with the infection.

Awareness, early recognition, and appropriate testing are key.

Systemic lupus erythematosus is associated with higher risks for all-cause and cardiovascular mortality for up to 5 years after acute myocardial infarction, a study finds.

From safety netting to documentation, understanding the five themes driving claims in emergency departments could help to protect patients and doctors.

Seven American aid workers who had been in Congo to fight the Ebola outbreak are quarantining at a new isolation facility in Kenya after the U.S. government introduced...

News All Time

How to Spot Anxiety in General Practice

Anxiety disorders are common but often missed in primary care, and routine screening, cognitive-behavioral therapy, and collaborative care may help GPs identify and manage them earlier.

Australia Seeks to Reverse Surge in Syphilis Cases

Syphilis has reemerged as a major public health threat across Australia but signs indicate that things might be improving.

Why This Painful Disorder Can Take a Decade-Plus to Diagnose

A connective tissue disorder with wide-ranging symptoms, hypermobile Ehlers-Danlos syndrome can lead to serious complications and harm from a medical system that doesn’t understand it.

Finding the Mystery to Trigger-Induced Atrial Fibrillation

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

Getting Blood Into Ambulances Matters in Trauma Cases

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

GSK's Jemperli Meets Main Goal in Mid-stage Rectal Cancer Trial

GSK said on Monday its cancer drug Jemperli met the primary goal of a ⁠mid-stage trial, with a clinically significant rate of patients showing no detectable signs of cancer...

Screening Reveals High Rate of EoE in Pediatric Asthma

Symptom-based screening in pediatric asthma and allergy clinics identifies a previously unrecognized high prevalence of eosinophilic esophagitis.

Alcohol Emergencies: When Is It More Than Intoxication?

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

German Hospital Treats US Ebola Patient Infected in Congo

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

Risk Stratification May ID Paraneoplastic Dermatomyositis

Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those classified into the high-risk group per international risk stratification criteria.

FDA Awards Breakthrough Status to Second Biologic for CLE

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

A New Class of Therapeutics Could End Immunosuppressants

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

Does Cancer Death Risk Increase After Transplantation?

De novo cancer may double the risk for long-term mortality among solid organ transplantation recipients, a population-based study shows.

Elevated Interferon Alfa May Reveal Sjögren Disease Subtype

Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.

Physical, Mental Factors Decrease COPD Inhaler Technique

Breath holding optimizes inhaler use regardless of dexterity or cognition challenges.

Autoimmune Diseases Respond to Teclistamab but With Risks

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Recommended News For You

A study outlines the need for policies that enhance cancer patients' autonomy and information.

Cancer Patients' Depression May Be Helped by Psilocybin.

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

Spouses of Cancer Patients May Be at Increased Risk of Suicide

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

Decrease seen in in situ breast cancer since 2009

Recommended Articles For You

Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology 

Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes 

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.

2.

Investigating the Relationship Between GERD and Anxiety/Depression.

3.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

4.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

5.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

1.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

2.

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics

3.

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care

4.

Tumor Dormancy and Cancer Recurrence: Mechanisms, Clinical Implications, and Future Directions

5.

What Is A Normal Fibrinogen Level, And How Can It Affect Your Health

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot